Author

Robbie Mazjner

Dana-Farber Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Amy K Erbe-Gurel· 1 shared Chantelle E BowersiD· 1 shared Courtney HimsworthiD· 1 shared Elizabeth Tucker· 1 shared Gaya NairiD· 1 shared Henrike P. MulleriD· 1 shared John AndersoniD· 1 shared Louis ChesleriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Amy K Erbe-Gurel

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

CD47 blockade augments anti-GD2 driven phagocytosis in vitro but fails to improve in vivo efficacy in immune competent, chemoresistant neuroblastoma preclinical models

Courtney Himsworth, Thomas John Jackson, Chantelle E Bowers, Sophie Munnings-Tomes, Gaya Nair, Henrike P. Muller, Elizabeth Tucker, Amy K Erbe-Gurel, PaulM. Sondel, Louis Chesler, Robbie Mazjner, John Anderson

This study shows CD47 blockade enhances anti-GD2 phagocytosis in vitro but does not improve in vivo efficacy in neuroblastoma models.

PLoS ONE · Oct 27, 2026Peer-reviewedImmunology